Pulmonx Chartis Tablet Console
Payments companies reported to CMS as associated with Pulmonx Chartis Tablet Console. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pulmonx Chartis Tablet Console, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pulmonx Chartis Tablet Console
These are the largest totals companies reported as associated with Pulmonx Chartis Tablet Console. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jonathan Kurman | Milwaukee, WI | Pulmonary Disease | $151,683.92 |
| Amit Mahajan | Falls Church, VA | Internal Medicine | $148,038.68 |
| Haley Hoy | Nashville, TN | Acute Care (Nurse Practitioner) | $142,123.33 |
| Rohit Goyal | Fredericksburg, VA | Critical Care Medicine (Internal Medicine) | $51,728.52 |
| Douglas Hogarth | Chicago, IL | Pulmonary Disease | $41,348.99 |
| Gerard Criner | Philadelphia, PA | Pulmonary Disease | $21,833.62 |
| Avi Cohen | Detroit, MI | Pulmonary Disease | $21,734.84 |
| Danille Prime | Wilmington, NC | Pulmonary Disease | $21,526.32 |
| Reza Ronaghi | Santa Monica, CA | Pulmonary Disease | $13,712.07 |
| Varun Shah | Knoxville, TN | Pulmonary Disease | $13,630.67 |
Prescribed Pulmonx Chartis Tablet Console?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.